Zacks Research Has Pessimistic Outlook of TEVA Q4 Earnings
Teva Pharmaceutical Industries Limited (NYSE:TEVA – Free Report) – Research analysts at Zacks Research reduced their Q4 2025 earnings estimates for Teva Pharmaceutical Industries in a research note issued to investors on Wednesday, March 5th. Zacks Research analyst R. Department now forecasts that the company will post earnings per share of $0.66 for the quarter, […]
Teva Pharmaceutical Industries Limited (NYSE:TEVA – Free Report) – Research analysts at Zacks Research reduced their Q4 2025 earnings estimates for Teva Pharmaceutical Industries in a research note issued to investors on Wednesday, March 5th. Zacks Research analyst R. Department now forecasts that the company will post earnings per share of $0.66 for the quarter, […]
